Compass Pathways (CMPS) stock surged Monday after President Donald Trump signed an executive order to ease the approval journey for psychedelic drugs. The order has two key elements. It provides a speedy Food and Drug Administration Commissioner’s National Priority Voucher (CNVP) for psychedelic drugs with Breakthrough Designation. The order also directs the attorney general to rapidly reschedule psychedelic drugs following…
